295 related articles for article (PubMed ID: 15289504)
1. Intracellular triggering of Fas aggregation and recruitment of apoptotic molecules into Fas-enriched rafts in selective tumor cell apoptosis.
Gajate C; Del Canto-Jañez E; Acuña AU; Amat-Guerri F; Geijo E; Santos-Beneit AM; Veldman RJ; Mollinedo F
J Exp Med; 2004 Aug; 200(3):353-65. PubMed ID: 15289504
[TBL] [Abstract][Full Text] [Related]
2. Fas/CD95 death receptor and lipid rafts: new targets for apoptosis-directed cancer therapy.
Mollinedo F; Gajate C
Drug Resist Updat; 2006; 9(1-2):51-73. PubMed ID: 16687251
[TBL] [Abstract][Full Text] [Related]
3. Edelfosine and perifosine induce selective apoptosis in multiple myeloma by recruitment of death receptors and downstream signaling molecules into lipid rafts.
Gajate C; Mollinedo F
Blood; 2007 Jan; 109(2):711-9. PubMed ID: 17003375
[TBL] [Abstract][Full Text] [Related]
4. Intracellular triggering of Fas, independently of FasL, as a new mechanism of antitumor ether lipid-induced apoptosis.
Gajate C; Fonteriz RI; Cabaner C; Alvarez-Noves G; Alvarez-Rodriguez Y; Modolell M; Mollinedo F
Int J Cancer; 2000 Mar; 85(5):674-82. PubMed ID: 10699948
[TBL] [Abstract][Full Text] [Related]
5. Involvement of mitochondria and recruitment of Fas/CD95 signaling in lipid rafts in resveratrol-mediated antimyeloma and antileukemia actions.
Reis-Sobreiro M; Gajate C; Mollinedo F
Oncogene; 2009 Sep; 28(36):3221-34. PubMed ID: 19561642
[TBL] [Abstract][Full Text] [Related]
6. Cytoskeleton-mediated death receptor and ligand concentration in lipid rafts forms apoptosis-promoting clusters in cancer chemotherapy.
Gajate C; Mollinedo F
J Biol Chem; 2005 Mar; 280(12):11641-7. PubMed ID: 15659383
[TBL] [Abstract][Full Text] [Related]
7. Lipid rafts and Fas/CD95 signaling in cancer chemotherapy.
Gajate C; Mollinedo F
Recent Pat Anticancer Drug Discov; 2011 Sep; 6(3):274-83. PubMed ID: 21762074
[TBL] [Abstract][Full Text] [Related]
8. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
Mitsiades N; Poulaki V; Tseleni-Balafouta S; Koutras DA; Stamenkovic I
Cancer Res; 2000 Aug; 60(15):4122-9. PubMed ID: 10945619
[TBL] [Abstract][Full Text] [Related]
9. In vitro and In vivo selective antitumor activity of Edelfosine against mantle cell lymphoma and chronic lymphocytic leukemia involving lipid rafts.
Mollinedo F; de la Iglesia-Vicente J; Gajate C; Estella-Hermoso de Mendoza A; Villa-Pulgarin JA; de Frias M; Roué G; Gil J; Colomer D; Campanero MA; Blanco-Prieto MJ
Clin Cancer Res; 2010 Apr; 16(7):2046-54. PubMed ID: 20233887
[TBL] [Abstract][Full Text] [Related]
10. The antitumor ether lipid ET-18-OCH(3) induces apoptosis through translocation and capping of Fas/CD95 into membrane rafts in human leukemic cells.
Gajate C; Mollinedo F
Blood; 2001 Dec; 98(13):3860-3. PubMed ID: 11739199
[TBL] [Abstract][Full Text] [Related]
11. Redistribution of CD95, DR4 and DR5 in rafts accounts for the synergistic toxicity of resveratrol and death receptor ligands in colon carcinoma cells.
Delmas D; Rébé C; Micheau O; Athias A; Gambert P; Grazide S; Laurent G; Latruffe N; Solary E
Oncogene; 2004 Nov; 23(55):8979-86. PubMed ID: 15480430
[TBL] [Abstract][Full Text] [Related]
12. Lipid raft connection between extrinsic and intrinsic apoptotic pathways.
Gajate C; Gonzalez-Camacho F; Mollinedo F
Biochem Biophys Res Commun; 2009 Mar; 380(4):780-4. PubMed ID: 19338752
[TBL] [Abstract][Full Text] [Related]
13. Lipid rafts as major platforms for signaling regulation in cancer.
Mollinedo F; Gajate C
Adv Biol Regul; 2015 Jan; 57():130-46. PubMed ID: 25465296
[TBL] [Abstract][Full Text] [Related]
14. Membrane rafts segregate pro- from anti-apoptotic insulin-like growth factor-I receptor signaling in colon carcinoma cells stimulated by members of the tumor necrosis factor superfamily.
Remacle-Bonnet M; Garrouste F; Baillat G; Andre F; Marvaldi J; Pommier G
Am J Pathol; 2005 Sep; 167(3):761-73. PubMed ID: 16127155
[TBL] [Abstract][Full Text] [Related]
15. Proapoptotic role of Hsp90 by its interaction with c-Jun N-terminal kinase in lipid rafts in edelfosine-mediated antileukemic therapy.
Nieto-Miguel T; Gajate C; González-Camacho F; Mollinedo F
Oncogene; 2008 Mar; 27(12):1779-87. PubMed ID: 17891170
[TBL] [Abstract][Full Text] [Related]
16. Involvement of raft aggregates enriched in Fas/CD95 death-inducing signaling complex in the antileukemic action of edelfosine in Jurkat cells.
Gajate C; Gonzalez-Camacho F; Mollinedo F
PLoS One; 2009; 4(4):e5044. PubMed ID: 19352436
[TBL] [Abstract][Full Text] [Related]
17. Fas signaling induces raft coalescence that is blocked by cholesterol depletion in human RPE cells undergoing apoptosis.
Lincoln JE; Boling M; Parikh AN; Yeh Y; Gilchrist DG; Morse LS
Invest Ophthalmol Vis Sci; 2006 May; 47(5):2172-8. PubMed ID: 16639029
[TBL] [Abstract][Full Text] [Related]
18. Localization of Fas/CD95 into the lipid rafts on down-modulation of the phosphatidylinositol 3-kinase signaling pathway.
Bénéteau M; Pizon M; Chaigne-Delalande B; Daburon S; Moreau P; De Giorgi F; Ichas F; Rebillard A; Dimanche-Boitrel MT; Taupin JL; Moreau JF; Legembre P
Mol Cancer Res; 2008 Apr; 6(4):604-13. PubMed ID: 18403639
[TBL] [Abstract][Full Text] [Related]
19. Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways.
Suliman A; Lam A; Datta R; Srivastava RK
Oncogene; 2001 Apr; 20(17):2122-33. PubMed ID: 11360196
[TBL] [Abstract][Full Text] [Related]
20. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression.
Fulda S; Meyer E; Debatin KM
Cancer Res; 2000 Jul; 60(14):3947-56. PubMed ID: 10919673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]